DCM
Universal Safety Products, Inc.
There isn't enough reported data to score DCM yet.
DCM Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Weak |
DCM's revenue, profitability, cash flow and balance sheet are all currently weak.
DCM PE Valuation
DCM has no meaningful PE right now: it lost money over the past year.
DCM Forward outlook
There aren't enough analyst estimates for DCM to show an outlook.
DCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.05 | -272% |
| Q1 2026 | -$1.04 | -573% |
| Q4 2025 | -$0.08 | +$0.46 |
| Q3 2025 | $0.51 | +$0.61 |
| Q2 2025 | $1.19 | +$1.62 |
| Q1 2025 | $0.22 | +$0.39 |
| Q4 2024 | -$0.54 | -460% |
| Q3 2024 | -$0.10 | -138% |
DCM has swung to a loss: it lost $2.05 per share over the past year, after a profit the year before.
DCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $109.6K | -97% |
| Q1 2026 | $240.4K | -96% |
| Q4 2025 | $22.5K | -100% |
| Q3 2025 | $760K | -89% |
| Q2 2025 | $3.8M | -17% |
| Q1 2025 | $6.2M | +29% |
| Q4 2024 | $5.5M | +19% |
| Q3 2024 | $7.2M | +94% |
DCM's revenue has slid since its 2024 peak: $109,559 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -673% | -659 points |
| Q1 2026 | -419% | -435 points |
| Q4 2025 | -9700% | -9685 points |
| Q3 2025 | -122% | -132 points |
| Q2 2025 | -14% | -5.3 points |
| Q1 2025 | 16% | +25 points |
| Q4 2024 | -16% | -18 points |
| Q3 2024 | 9.4% | +14 points |
DCM's operating margin was −673% last quarter, down 659 points from the same quarter a year ago, near the bottom of its range since 2019.
DCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$733.2K | -127% |
| Q1 2026 | -$811.4K | -$499.8K |
| Q4 2025 | -$2.6M | -202% |
| Q3 2025 | $1.2M | +$3.3M |
| Q2 2025 | $2.8M | +$4M |
| Q1 2025 | -$311.6K | -182% |
| Q4 2024 | $2.5M | +$3M |
| Q3 2024 | -$2.1M | -541% |
DCM's free cash flow was −$3M over the past year, against $3M the year before.
DCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +27% | +624K shares |
| 1 year | +27% | +624K shares |
| 3 years | +27% | +624K shares |
| 5 years | +27% | +624K shares |
| Available history | +27% | +624K shares |
DCM has 3M diluted shares, up 27% from a year ago.
DCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 4.3x | High |
| Q4 2023 | 4.3x | High |
| Q3 2023 | 1.9x | Healthy |
| Q2 2023 | 2.0x | Healthy |
| Q1 2023 | 1.3x | Healthy |
| Q4 2022 | -0.2x | Net Cash |
| Q3 2022 | -0.5x | Net Cash |
| Q2 2022 | -26.9x | Net Cash |
DCM's net debt is about 4.3 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
DCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.5 | Neutral |
| Stochastic | 5.7 | Oversold |
DCM's weekly RSI is 37 (neutral) and its Stochastic is 6 (oversold).
DCM PE vs Industrials Sector
| Metric | DCM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
DCM has no meaningful PE right now: it lost money over the past year.
DCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.16 | 27% below |
| 20 week MA | $4.32 | 30% below |
| 50 week MA | $5.02 | 40% below |
| 100 week MA | $4.10 | 26% below |
| 200 week MA | $3.05 | 0.7% below |
DCM is in a downtrend: it's below all five of its weekly moving averages, and 0.7% below its 200-week average.
DCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.61 | $2.91 | +377% |
| 2021 | $2.91 | $3.64 | +25% |
| 2022 | $3.64 | $2.10 | -42% |
| 2023 | $2.10 | $1.66 | -21% |
| 2024 | $1.66 | $2.31 | +39% |
| 2025 | $2.31 | $5.00 | +116% |
| 2026 YTD | $5.00 | $3.03 | -39% |
DCM's yearly returns have swung widely, from +377% in 2020 to −42% in 2022. It's down 39% so far in 2026.